Over 1850 Total Lots Up For Auction at Six Locations - MA 04/30, NJ Cleansweep 05/02, TX 05/03, TX 05/06, NJ 05/08, WA 05/09

The University of Southampton enters the field of correlative in-vivo imaging by acquiring MILabs 3D/4D Optical/CT

Press releases may be edited for formatting or style | May 12, 2020 CT X-Ray


About Biomedical Imaging Unit, Southampton:
The Biomedical Imaging Unit is a joint University Hospitals Southampton NHS Foundation Trust (UHS)/University of Southampton (UoS) facility for high quality/high resolution diagnostic and research imaging. Accredited under UKAS to ISO 15189, this core facility carries out research work for UoS, other universities and research institutes, industry, and hospitals. As a multi-user facility supported by ten highly experienced and expert imaging staff, the Biomedical Imaging Unit can provide a complete supporting workflow for internal and external users in all aspects of imaging from experimental design, proof of concept tests, user training, sample preparation, imaging, interpretation, processing, and analysis of specimens, data management and archiving. For more information: https://www.southampton.ac.uk/biu/index.page

stats
DOTmed text ad

New Fully Configured 80-slice CT in 2 weeks with Software Upgrades for Life

For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.

stats
About MILabs, B.V.
This fast-growing Dutch company has a history of providing a continuum of innovations to expand the applications of preclinical molecular imaging. With its latest adaptive platform, MILabs has succeeded at commercializing a scalable imaging platform, able to accommodate exclusive Optical tomography and ultra-high-resolution CT imaging as well as high-definition nuclear PET and SPECT techniques. The company has built a strong brand based on its mission of “Making Molecular Imaging Clear” complemented by multiparametric imaging and unique concurrent within subject analysis of multiple probes. it provides efficient translational systems for both diagnostic and therapy applications while minimizing the use of animal models. For more information, visit: www.milabs.com or contact MILabs at info@milabs.com

Back to HCB News

You Must Be Logged In To Post A Comment